Mary Ndiaye

11PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMolecular targetsEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 08, 2026
SIRT6 promotes a mesenchymal, invasive phenotype in melanoma.

|May 18, 2026
Mechanistic and preclinical evaluation of SIRT3 as a therapeutic target in melanoma.

|Feb 27, 2026
Mechanisms of the Antiproliferative Effects of SIRT6 Inhibition in Melanoma: A Multi-Omics Analysis.

Karla B Anaya Aldrete, Durdana Muntaqua, Liz M Garcia-Peterson

|Jun 17, 2025
PLK4 is a potential therapeutic target in nonmelanoma skin cancers: Evidence from molecular and in vivo studies.

Mary A Ndiaye, Debra R Garvey, Gagan Chhabra

|Jan 06, 2024
Role of PLK1/NUMB/NOTCH in epithelial-mesenchymal transition in human melanoma.

Gagan Chhabra, Chandra K Singh, Mary A Ndiaye

|Nov 25, 2023
Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer.

Shengqin Su, Mary Ann Ndiaye, Glorimar Guzmán-Pérez

Pageof 2

Frequent Collaborators

9 joint publications

Nihal Ahmad

7 joint publications

Chandra K Singh

5 joint publications

Gagan Chhabra

3 joint publications

Shengqin Su